Ductal Carcinoma in Situ
📧 Sign up to get email alerts when something new happens for Ductal Carcinoma in Situ.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-17Clinical Trial Update: Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating high-dose vitamin D on cancer biomarkers and breast cancer tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-02-18Clinical Trial Update: Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS) [Phase 2]
Phase 2 trial evaluating Magtrace for delayed sentinel lymph node biopsy in Ductal Carcinoma in Situ has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-05Clinical Trial Update: KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer [NA]
A clinical trial evaluating KeraStat Skin Therapy for radiation dermatitis in patients with newly diagnosed stage 0-IIIA breast cancer has b…
-
CLINICAL_TRIALS withdrawal · 2017-04-13Clinical Trial Update: Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer [NA]
This clinical trial investigating stereotactic image-guided navigation during breast reconstruction in patients with breast cancer has been …
-
CLINICAL_TRIALS withdrawal · 2014-10-15Clinical Trial Update: Magnetic Resonance Thermal Image Guided Laser Interstitial Thermal Therapy in Treating Patients With Breast Cancer [NA]
A clinical trial evaluating Magnetic Resonance Thermal Image Guided Laser Interstitial Thermal Therapy for breast cancer has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-11-29Clinical Trial Update: Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS [Phase 3]
A Phase 3 trial evaluating risedronate to improve bone mineral density in postmenopausal women with ductal carcinoma in situ has been withdr…